Halliday Stephen J, Shi Huang, Brittain Evan L, Hemnes Anna R
1 Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
2 Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Pulm Circ. 2019 Jan-Mar;9(1):2045894018814182. doi: 10.1177/2045894018814182. Epub 2018 Nov 13.
We conducted a survey of pulmonary arterial hypertension (PAH) patients and healthy controls who use either a smartphone or wearable fitness device that tracks daily step count. We found that PAH patients have markedly reduced activity levels compared to controls, after controlling for confounders.
我们对使用智能手机或可追踪每日步数的可穿戴健身设备的肺动脉高压(PAH)患者和健康对照者进行了一项调查。我们发现,在控制混杂因素后,PAH患者的活动水平与对照者相比显著降低。